• 페이스북 공유
  • 트위터 공유
  • 미투데이 공유
  • URL복사
  • 더보기
  • 관심의료진 등록

김윤경

  • 진료과

    소아청소년과

  • 전문진료분야

    발열, 감염질환, 결핵, 예방접종 (화 오전-예방접종 클리닉)

  • 담당클리닉

    예방접종 클리닉

김윤경

김윤경 교수의 진료시간표 진료예약

진료과/센터 전문진료과목
소아청소년과 -
종일
- - - - 발열, 감염질환, 결핵, 예방접종 (화 오전-예방접종 클리닉)

김윤경 교수의 상세정보

학력

more
  • 1990  ~  1996  :  서울대학교 의과대학 학사
  • 1999  ~  2001  :  서울대학교 의과대학원 석사
  • 2001  ~  2003  :  서울대학교 의과대학원 박사

경력

more
  • 2001  ~  2004  :  서울대학교 병원, 임상 강사
  • 2004  ~  2005  :  고려대학교 구로병원 임상조교수
  • 2005  ~  2009  :  고려대학교 의과대학 조교수
  • 2010  ~   :  고려대학교 의과대학 부교수
  • 2010  ~  2011  :  Balyor College of Medicine, 조교수
  • 2016  ~   :  고려대학교 의과대학 교수

수상내역

more
  • 2001 .10  :  석천논문상, 대한소아과학회
  • 2001 .05  :  우수초록상, 대한화학요법학회
  • 2003 .05  :  우수초록상, 대한화학요법학회
  • 2005 .05  :  우수초록상, 대한감염학회
  • 2011 .06  :  young inverstigator travel grant, 세계감염학회
  • 2015 .02  :  고대안산병원 우수연구자포상
  • 2018 .10  :  MSD 연구상, 대한소아감염학회

학회활동

more
  •  ~   :  대한소아과학회, 대한감염학회, 대한화학요법학회, 대한의료관련감염관리학회, 한국소아감염병학회, 세계감염학회, 미국감염학회 회원
  •  ~   :  대한소아감염학회 이사
  •  ~   :  대한소아과학회 감염위원 및 보험자문위원
  •  ~   :  대한소아감염학회지 심사위원
  •  ~   :  대한백신학회 이사
  •  ~   :  대한화학요법학회 이사
  •  ~   :  대한화학요법학회 백신연구회 위원장
  •  ~   :  대한의료관련감염관리학회 이사
  •  ~   :  질병관리청 생물테러감시 및 예방접종 심의위원회 위원
  •  ~   :  식품안전관리처 약물이상반응 자문위원
  •  ~   :  경기도 코로나백신 이상반응 신속대응팀 자문위원

논문

more
  • [SCI] (Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children)
  • [SCI] (Survey on the Effects of Educational Intervention in Parents' Perceptions and Decisions Regarding Influenza Vaccination for Their Children Aged 6–59 Months)
  • [SCI] (Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea)
  • [SCI] (Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014-2015 and 2015-2016 influenza seasons: a cohort study)
  • [SCI] (A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III,observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration)
  • [SCI] (Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children)
  • [SCI] (Pediatric intensive care unit admission due to respiratory syncytial virus: Retrospective multicenter study)
  • [SCI] (One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants)
  • [SCI] (Etiology of Invasive Bacterial Infections in Immunocompetent Children in Korea (2006-2010): a Retrospective Multicenter Study (vol 33, e45, 2018))
  • [SCI] (A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age -Pediatric)
  • [SCI] (Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6-35 Months)
  • [SCI] (Recommended immunization schedule for children and adolescents: Committee on infectious diseases of the korean pediatric society)
  • [SCI] (Etiology of Invasive Bacterial Infections in Immunocompetent Children in Korea (2006-2010): a Retrospective Multicenter Study)
  • [SCI] (Genetic structures of invasive Streptococcus pneumoniae isolates from Korean children obtained between 1995 and 2013)
  • [SCI] (A Randomized, Double-blind, Active-controlled Clinical Trial of a Cell Culture-derived Inactivated Trivalent Influenza Vaccine (NBP607) in Healthy Children 6 Months Through 18 Years of Age)
  • [SCI] (Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study)
  • [SCI] (Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea)
  • [SCI] (A Survey of Parental Perception and Pattern of Action in Response to Influenza-like Illness in Their Children: Including Healthcare Use and Vaccination in Korea)
  • [SCI] (Hemagglutination inhibiting antibody persistence 1year after influenza vaccination in Korean children and Adolescents)
  • [SCI] (Migrating Persistent Pulmonary Consolidation in a Child: A Case of Follicular Bronchiolitis)
  • [SCI] (Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP similar to T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea)
  • [SCI] (The impact of an educational intervention on parents' decisions to vaccinate their)
  • [SCI] (Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine in healthy adolescents in Korea&#8212;A randomized trial)
  • [SCI] (Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea)
  • [SCI] (Recommended immunization schedule for children and adolescents: Immunization Guideline (8th edition) release by the Korean Pediatric Society in 2015.)
  • [SCI] (Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children)
  • [SCI] (The Association between Influenza Treatment and Hospitalization-Associated Outcomes among Korean Children with Laboratory-Confirmed Influenza)
  • [SCI] (Serotype distribution and antibiotic resistance of Streptococcus pneumonia isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea 2006&#8211;2010)
  • [SCI] (Varicella and Varicella Vaccination in South Korea)
  • [SCI] (Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children 6 through 35 months of age)
  • [SCI] (Clinical manifestations of respiratory adenoviral infection among hospitalized children in Korea)
  • [SCI] (Immunogenicity and safety of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, compared with HiberixTM in Korean infants and children: A randomized trial)
  • [SCI] (Severe Osteomyelitis as a Complication of Tokyo-172 BCG Vaccination)
  • [SCI] (Response to Primary and Booster Vaccination With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants)
  • [SCI] (Current status and clinical presentations of invasive neonatal Group B streptococcal infections in Korea)
  • [SCI] (Etiology of Invasive Bacterial Infections in Immunocompetent Children in Korea (1996-2005): A Retrospective Multicenter Study)
  • [SCI] (Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to < 18 years of age: A prospective, open-label, multi-center trial)
  • [SCI] (The Causative Organisms of Bacterial Meningitis in Korean Children in 1996-2005)
  • [학술진흥재단] (A childhood case of spinal tuberculosis misdiagnosed as muscular dystrophy)
  • [SCI] (BURDEN OF VIRAL RESPIRATORY DISEASE HOSPITALIZATIONS AMONG CHILDREN IN A COMMUNITY OF SEOUL)
  • [SCI] (Control of extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children’s hospital by changing antimicrobial agent usage policy)
  • [SCI] (Genetic Variability of the Fusion Protein and Circulation Patterns of Genotypes of the Respiratory Syncytial Virus)

최종수정일 : 2021.07.29